Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)NCT04831281LeonaBioPhase 2Terminated2023-04-19Actual
Study of ARO-ANG3 in Adults With Mixed DyslipidemiaNCT04832971Arrowhead PharmaceuticalsPhase 2Completed2022-08-30Actual
A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection FractionNCT04836182IONSPhase 2Completed2022-10-19Actual
VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyNCT04842747VERUPhase 3Completed2022-07-06Actual
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentNCT04844749VERUPhase 3Terminated2023-05-04Actual
Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in AdultsNCT04845178AEONPhase 2Completed2024-06-19Actual
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)NCT04845620ARQTPhase 3Completed2023-06-01Actual
A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.NCT04847544ALDXPhase 2Completed2021-10-15Actual
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCMNCT04848506CytokineticsPhase 2, Phase 3Enrolling by invitation2028-03Estimated
A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)NCT04849741IONSPhase 3Active not recruiting2025-08-22Actual
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical DystoniaNCT04849988AEONPhase 2Completed2022-07-11Actual
Study of SAB-176 in Healthy Adult ParticipantsNCT04850898SABSPhase 2Completed2021-10-08Actual
A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS MutationsNCT04854434KPTIPhase 2Terminated2022-06-24Actual
Safety of REL-1017 for Major Depressive DisorderNCT04855760RLMDPhase 3Completed2023-07-27Actual
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionNCT04856085VIRPhase 2Completed2026-03-16Actual
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne VulgarisNCT04856917Vanda PharmaceuticalsPhase 2Completed2022-02-01Actual
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis SuppurativaNCT04856930Vanda PharmaceuticalsPhase 2Completed2022-07-15Actual
Evaluation of ADG20 for the Prevention of COVID-19NCT04859517IVVDPhase 2, Phase 3Terminated2022-11-04Actual
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast CancerNCT04869943VERUPhase 3Terminated2024-01-09Actual
A Study of AL102 in Patients With Progressing Desmoid TumorsNCT04871282IMNMPhase 2, Phase 3Active not recruiting2025-12-03Actual
Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical DystoniaNCT04871451AEONPhase 2Completed2023-07-24Actual
A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and SarcopeniaNCT04874350LPCNPhase 2Completed2023-12-18Actual
A Trial to Investigate Recovery From COVID-19 With C21 in Adult SubjectsNCT04880642Vicore Pharma ABPhase 3Completed2022-04-25Actual
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson DiseaseNCT04884815RAREPhase 1, Phase 2Active not recruiting2029-03Estimated
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseNCT04886063LeonaBioPhase 2, Phase 3Terminated2024-10-23Actual
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung CancerNCT04892472NovoCure GmbHPhase 2Terminated2025-01-10Actual
CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin SyndromeNCT04893486PVLAPhase 2Completed2023-03-13Actual
A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric ParticipantsNCT04903288PTC TherapeuticsPhase 2Active not recruiting2023-05-22Actual
Trial of AD113 and Atomoxetine in OSA Patients With HypertensionNCT04905979ApnimedPhase 2Completed2023-01-31Actual
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)NCT04906421SGMTPhase 2Completed2023-10-02Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.